We build advanced AI solutions to accelerate the journey from bench to bedside.
We build advanced AI solutions to accelerate the journey from bench to bedside.
We build advanced AI solutions to accelerate the journey from bench to bedside.
We build advanced AI solutions to accelerate the journey from bench to bedside.
Our mission is to transform life sciences R&D so that treatments get into the hands of patients faster, cheaper and with less risk.
Our mission is to transform life sciences R&D so that treatments get into the hands of patients faster, cheaper and with less risk.
Our mission is to transform life sciences R&D so that treatments get into the hands of patients faster, cheaper and with less risk.
The pace of discovery of candidate therapeutics has drastically increased thanks to new methods of computational drug discovery. But drug development has gotten increasingly long and expensive, severely bottlenecking the process of getting promising new treatments into the hands of patients.
By reducing the time and cost of translational and clinical development, we can unlock the flow of new therapies, allowing innovators and investors to "take more shots on goal" by efficiently using resources.
We built Inquisite to give life sciences innovators the right set of tools to efficiently move through the development process, using AI to complement human expertise in the process of bringing new therapeutics to market.
The pace of discovery of candidate therapeutics has drastically increased thanks to new methods of computational drug discovery. But drug development has gotten increasingly long and expensive, severely bottlenecking the process of getting promising new treatments into the hands of patients.
By reducing the time and cost of translational and clinical development, we can unlock the flow of new therapies, allowing innovators and investors to "take more shots on goal" by efficiently using resources.
We built Inquisite to give life sciences innovators the right set of tools to efficiently move through the development process, using AI to complement human expertise in the process of bringing new therapeutics to market.
The pace of discovery of candidate therapeutics has drastically increased thanks to new methods of computational drug discovery. But drug development has gotten increasingly long and expensive, severely bottlenecking the process of getting promising new treatments into the hands of patients.
By reducing the time and cost of translational and clinical development, we can unlock the flow of new therapies, allowing innovators and investors to "take more shots on goal" by efficiently using resources.
We built Inquisite to give life sciences innovators the right set of tools to efficiently move through the development process, using AI to complement human expertise in the process of bringing new therapeutics to market.
Learn More
Learn More
Learn More
Learn More
About Inquisite
About Inquisite
About Inquisite
About Inquisite
Inquisite was developed by two faculty members at Duke University, Jon Reifschneider and Dr. Pramod Singh, who teamed up to start Inquisite after a combined 40+ years in industry leading the development of AI systems.
Their conviction that technology, specifically AI, can play a major role in unlocking barrier to efficient translation in life sciences led them to found Inquisite with the mission of transforming the life sciences development process to get treatments into the hands of patients faster with lower risk.
As a spinout from Duke University, Inquisite was organized as a Public Benefit Corporation in 2023 to deliver on its societal mission. Our team is proudly based in the Research Triangle Park area of North Carolina.
Inquisite was developed by two faculty members at Duke University, Jon Reifschneider and Dr. Pramod Singh, who teamed up to start Inquisite after a combined 40+ years in industry leading the development of AI systems.
Their conviction that technology, specifically AI, can play a major role in unlocking barrier to efficient translation in life sciences led them to found Inquisite with the mission of transforming the life sciences development process to get treatments into the hands of patients faster with lower risk.
As a spinout from Duke University, Inquisite was organized as a Public Benefit Corporation in 2023 to deliver on its societal mission. Our team is proudly based in the Research Triangle Park area of North Carolina.
Inquisite was developed by two faculty members at Duke University, Jon Reifschneider and Dr. Pramod Singh, who teamed up to start Inquisite after a combined 40+ years in industry leading the development of AI systems.
Their conviction that technology, specifically AI, can play a major role in unlocking barrier to efficient translation in life sciences led them to found Inquisite with the mission of transforming the life sciences development process to get treatments into the hands of patients faster with lower risk.
As a spinout from Duke University, Inquisite was organized as a Public Benefit Corporation in 2023 to deliver on its societal mission. Our team is proudly based in the Research Triangle Park area of North Carolina.
Powering life science innovation with advanced AI
Enabling organizations to get treatments into the hands of patients faster, more efficiently and with less risk.
Get Started Free
Powering life science innovation with advanced AI
Enabling organizations to get treatments into the hands of patients faster, more efficiently and with less risk.
Get Started Free
Powering life science innovation with advanced AI
Enabling organizations to get treatments into the hands of patients faster, more efficiently and with less risk.
Get Started Free
Powering life science innovation with advanced AI
Enabling organizations to get treatments into the hands of patients faster, more efficiently and with less risk.
Get Started Free
Accelerating science with cutting-edge AI for a better world.
Resources
Copyright © 2024 Spotlight Labs Inc.
Accelerating science with cutting-edge AI for a better world.
Resources
Copyright © 2024 Spotlight Labs Inc.
Accelerating science with cutting-edge AI for a better world.
Resources
Copyright © 2024 Spotlight Labs Inc.
Accelerating science with cutting-edge AI for a better world.
Resources
Copyright © 2024 Spotlight Labs Inc.